Breaking News

AMRI Accelerates Restructuring

New initiative expected to bring annual savings to $10 million

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

AMRI has taken several initiatives in 4Q11 intended to shrink the company’s workforce, right size capacity, and reduce operating costs in 2012. The actions will “better align the business to current and expected market conditions and are expected to improve the company’s overall cost competitiveness and increase cash flow generation,” according to an AMRI statement. In November 2011, the company announced that it would exit all internal R&D activities. The workforce reduct...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters